Posted by Michael Wonder on 28 Mar 2021
Landmark PBS medicines listings to provide hope for thousands of Australians
28 March 2021 - There is new hope for thousands of Australians living with breast cancer, lung cancer, osteoporosis and asthma with landmark new and amended medicines listings on the PBS from 1 April.
From 1 April, Kisqali (ribociclib) is having its listing expanded on the PBS to be used in combination with Fulvestrant Sandoz (fulvestrant) for patients with hormone receptor positive and human epidermal growth factor receptor 2 negative unresectable advanced or metastatic breast cancer.
